HONG KONG — A new technology promises to deliver levodopa at more constant levels over time. It depends on a folded, accordion-like structure inside a gelatin capsule. When swallowed, the capsule ...
Levodopa, a precursor of dopamine, has served for over half a century as the most effective symptomatic treatment for Parkinson’s disease. Following oral administration, levodopa crosses the ...
Amneal Pharmaceuticals has announced positive topline results from the phase 3 RISE-PD trial evaluating a novel formulation of carbidopa/levodopa for patients with Parkinson’s disease (PD) who have ...
Medications for Parkinson’s may help replenish dopamine levels or mimic its effects, addressing the deterioration of brain cells that produce this neurotransmitter. Carbidopa-levodopa is commonly the ...
RODEN, Netherlands, Jan. 18, 2024 /PRNewswire/ -- PureIMS, a pharmaceutical company focused on the development of innovative inhalation products, this week reported it has completed a comparative ...
Acorda Therapeutics ($ACOR) moved a step closer to collecting the payoff from its $525 million acquisition of Civitas, maker of an inhaled levodopa, in the scramble ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results